Subunit composition of the mammalian serine-palmitoyltransferase defines the spectrum of straight and methyl-branched long-chain bases.
Level 5 - mechanism / opinion, no new human data
In vitro bench and cell culture mechanistic study
PubMed 32576697 · doi:10.1073/pnas.2002391117
What was done
Using mammalian cell models deficient in individual core subunits of serine-palmitoyltransferase (SPTLC1, SPTLC2, and SPTLC3), the authors evaluated the requirement of each subunit for enzyme activity and characterized the resulting spectrum of long-chain base (LCB) sphingolipid products.
What was found
The abstract reports qualitative biochemical relationships without quantitative numerical metrics: - SPTLC1 is essential for enzymatic activity. - SPTLC2 and SPTLC3 are partially redundant but differ in substrate utilization and product profiles. - The SPTLC1/SPTLC2 complex specifically produced C18, C19, and C20 LCBs. - The SPTLC1/SPTLC3 complex generated a broader product spectrum, with anteiso-branched-C18 SO (meC18SO) identified as its primary product. - meC18SO is synthesized from anteiso-methyl-palmitate derived from isoleucine catabolism, is incorporated into ceramides and complex sphingolipids, and is present in human LDL and HDL.
Why it matters
These findings explain how subunit composition regulates the structural diversity of mammalian sphingolipids, linking isoleucine catabolism directly to the production of branched-chain sphingolipids present in circulating human lipoproteins.
Limits
The abstract provides no quantitative data, error ranges, or enzyme kinetic parameters. Results are based primarily on in vitro deficient cell lines, and the in vivo functional consequences in intact organisms were not assessed in the abstract.
Cited by
- supports Medium-chain triglycerides (MCTs) do not serve as substrates for ceramide synthesis.